Male and female patients diagnosed with androgenic alopecia three herbal mixtures hair serum, hair thining, androgenic alopecia, minoxidil
Conditions
Interventions
The study product containing a mixture of three herbs consists of three natural extracts: Phyllanthus emblica (Indian gooseberry), Thunbergia laurifolia (blue trumpet vine), and Citrus hystrix (kaffir
Study product,Minoxidil
Sponsors
Chanat Kumtornrut
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Male and female patients diagnosed with androgenic alopecia. 2. Aged 18-65 years. 3. The stages of androgenic alopecia in males, according to the revised Hamilton's classification, are at levels II, III, III vertex, or IV. The stages of androgenic alopecia in females, according to the Savin scale, are at levels I-2, I-3, I-4, or II-1.
Exclusion criteria
Exclusion criteria: 1. Participants with other hair or scalp diseases, such as seborrheic dermatitis, scalp psoriasis, scalp fungal infections, telogen effluvium, or scarring alopecia. 2. Participants with medical conditions or chronic illnesses that cause hair loss, such as cancer, anemia, thyroid hormone abnormalities, immunodeficiency, or connective tissue diseases. 3. Participants who have undergone hair transplant surgery. 4. Participants who need to use androgen hormones or anti-androgen medications, such as spironolactone, or use hormonal medications for contraception or hormone regulation. 5. Participants who are pregnant or breastfeeding. 6. Participants with a history of allergy to minoxidil or any other components in the topical minoxidil solution.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair density baseline, week6, week 12, week 24 by fotofinder dermoscope (Total hair counts, teminal hair counts, vellus hair counts)) | — |
Secondary
| Measure | Time frame |
|---|---|
| global photographic evaluation baseline, week6, week 12, week 24 the standardized 7-point rating score using scalp photographs from -3; significant disease progression to +3; significant improvement.,hair growth questionnaire baseline, week6, week 12, week 24 growth of hair, amount of noticeable new hair, visibility of the scalp, rate of hair loss | — |
Countries
Thailand
Contacts
Public ContactChanat Kumtornrut
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed